ImmunityBio (STU:26CA) Beginning Cash Position : €244.52 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio Beginning Cash Position?

ImmunityBio's Beginning Cash Position for the quarter that ended in Mar. 2024 was €244.52 Mil.

ImmunityBio's quarterly Beginning Cash Position increased from Sep. 2023 (€41.07 Mil) to Dec. 2023 (€163.50 Mil) and increased from Dec. 2023 (€163.50 Mil) to Mar. 2024 (€244.52 Mil).

ImmunityBio's annual Beginning Cash Position increased from Dec. 2021 (€31.06 Mil) to Dec. 2022 (€171.13 Mil) but then declined from Dec. 2022 (€171.13 Mil) to Dec. 2023 (€96.25 Mil).

ImmunityBio Beginning Cash Position Historical Data

The historical data trend for ImmunityBio's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunityBio Beginning Cash Position Chart

ImmunityBio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

85.75

62.46

31.06

171.13

96.25

ImmunityBio Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial													98.04	81.97	41.07	163.50	244.52

ImmunityBio Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

ImmunityBio Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of ImmunityBio's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunityBio (STU:26CA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (STU:26CA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

IBRX:USA 26CA:Germany

Address

3530 John Hopkins Court, San Diego, CA, USA, 92121

Website

https://www.immunitybio.com

ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.

ImmunityBio (STU:26CA) Headlines

No Headlines